hero image
Matthew Gentry - University of Florida. Gainesville, FL, US

Matthew Gentry Matthew Gentry

Professor & Chair | University of Florida

Gainesville, FL, UNITED STATES

Matthew Gentry is a prominent brain metabolism scientist and chair of biochemistry and molecular biology.

Biography

Matthew Gentry is a prominent brain metabolism scientist who has made seminal discoveries regarding brain glycogen and glucose metabolism and how perturbations in these pathways impact neuro-centric diseases. Matthew has nearly 20 years of experience working on glycogen storage diseases and is director of the NIH-funded Lafora Epilepsy Cure Initiative. He is a professor and chair of the Department of Biochemistry and Molecular Biology in the College of Medicine.

Areas of Expertise (5)

Brain Metabolism

Ewing sarcoma

Glycogen

Glycogen Storage Diseases

Lafora Disease

Media Appearances (5)

University of Kentucky researchers discover fundamental roles of glucosamine in brain

University of Kentucky News  online

2021-05-26

Using novel imaging methods for studying brain metabolism, University of Kentucky researchers have identified the reservoir for a necessary sugar in the brain. Glycogen serves as a storage depot for the sugar glucose.

view more

An unprecedented impact: a series of fact sheets on COVID-19 and biomedical research

United for Medical Research  online

2020-07-01

We must maintain and strengthen our nation’s investment in medical research through the National Institutes of Health.

view more

The coronavirus pandemic claims another victim: Medical research for deadly rare diseases

The Washington Post  online

2020-06-04

Anissa Merriam was a vibrant teenager, a talented artist who loved anime and excelled in difficult classes. But at 14, she started dropping her pencil and her hairbrush, and struggled with her studies.

view more

NINDS announces 20 new recipients of Research Program Award

National Institute of Neurological Disorders and Stroke  online

2020-05-18

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, announced the latest recipients of the R35 Research Program Award (RPA).

view more

Preclinical study of therapeutic strategy for lafora disease shows promise

WUKY  online

2019-10-02

When it comes to medical breakthroughs, sometimes one can never know when basic and rudimentary research might bear fruit. That’s certainly the case with the person you’re about to meet and the specific type of disease he’s been working to cure.

view more

Articles (4)

In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues

EMBO Molecular Medicine

Lyndsay E A Young, et. al

2022-09-05

Glycogen dysregulation is a hallmark of aging, and aberrant glycogen drives metabolic reprogramming and pathogenesis in multiple diseases. However, glycogen heterogeneity in healthy and diseased tissues remains largely unknown. Herein, we describe a method to define spatial glycogen architecture in mouse and human tissues using matrix-assisted laser desorption/ionization mass spectrometry imaging.

view more

High-dimensionality reduction clustering of complex carbohydrates to study lung cancer metabolic heterogeneity

High-dimensionality reduction clustering of complex carbohydrates to study lung cancer metabolic heterogeneity.

Lindsey R.Conroy, et. al

2022-04-19

The tumor microenvironment contains a heterogeneous population of stromal and cancer cells that engage in metabolic crosstalk to ultimately promote tumor growth and contribute to progression. Due to heterogeneity within solid tumors, pooled mass spectrometry workflows are less sensitive at delineating unique metabolic perturbations between stromal and immune cell populations. Two critical, but understudied, facets of glucose metabolism are anabolic pathways for glycogen and N-linked glycan biosynthesis.

view more

Activation of Drp1 promotes fatty acids-induced metabolic reprograming to potentiate Wnt signaling in colon cancer

Cell Death & Differentiation

Xiaopeng Xiong, et. al

2022-03-24

Cancer cells are known for their ability to adapt variable metabolic programs depending on the availability of specific nutrients. Our previous studies have shown that uptake of fatty acids alters cellular metabolic pathways in colon cancer cells to favor fatty acid oxidation. Here, we show that fatty acids activate Drp1 to promote metabolic plasticity in cancer cells. Uptake of fatty acids (FAs) induces mitochondrial fragmentation by promoting ERK-dependent phosphorylation of Drp1 at the S616 site.

view more

Analysis of circulating metabolites to differentiate Parkinson’s disease and essential tremor

Neuroscience Letters

Elena A. Ostrakhovitch, et. al

2022-01-06

Parkinson’s disease (PD) and essential tremor (ET) are two common adult-onset tremor disorders in which prevalence increases with age. PD is a neurodegenerative condition with progressive disability. In ET, neurodegeneration is not an established etiology. We sought to determine whether an underlying metabolic pattern may differentiate ET from PD.

view more

Media

Publications:

Documents:

Photos:

Headshot loading image

Videos:

Audio/Podcasts:

Languages (1)

  • English